(Q34000242)

30 July 2017

1 reference

title

Oxygen-exacerbated bleomycin pulmonary toxicity (English)

1 reference

30 July 2017

Oxygen-Exacerbated Bleomycin Pulmonary Toxicity (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)60489-3

3 November 2022

2

J. H. Ryu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704473

3 November 2022

author name string

T. S. Ingrassia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704473

3 November 2022

V. F. Trastek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704473

3 November 2022

E. C. Rosenow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704473

3 November 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

full work available at URL

30 July 2017

https://api.elsevier.com/content/article/PII:S0025619612604893?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)60489-3

https://api.elsevier.com/content/article/PII:S0025619612604893?httpAccept=text/plain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)60489-3

3 November 2022

1 reference

30 July 2017

volume

66

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

173-178

1 reference

A clinical review of bleomycin--a new antineoplastic agent

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Anticancer drugs: reduction of pulmonary toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Reactivation of bleomycin lung toxicity following oxygen administration. A second response to corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Bleomycin and subsequent anaesthesia: A retrospective study at Vancouver General Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Mechanism of bleomycin action: studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Modifications of the effect of bleomycin in the somatic mutation and recombination test in Drosophila melanogaster.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Inhibition of the genotoxicity of bleomycin by superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Modifiers of free radicals inhibit in vitro the oncogenic actions of x-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Correlation between the anti-oxidant enzyme activities of blood fractions and the yield of bleomycin-induced chromosome damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Pulmonary strategies of antioxidant defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Mechanisms of drug-induced pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Bronchoalveolar lavage cell populations in bleomycin lung toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

A molecular basis for bleomycin-induced pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Normobaric Oxygen Toxicity of the Lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Pulmonary oxygen toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960489-3

New antibiotics, bleomycin A and B

7 January 2021

1

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)60489-3

Modification of oxygen toxicity after lung injury by bleomycin in hamsters

3 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)60489-3

Early diagnosis of bleomycin pulmonary toxicity using bronchoalveolar lavage in dogs

3 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)60489-3

Pulmonary oxygen toxicity: a review

3 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)60489-3

3 November 2022

Identifiers

1 reference

30 July 2017

1 reference